The issue with Synlab was first identified in December 2020, when the firm spotted inconsistencies in quality control and voluntarily suspended its accreditation for drug testing in criminal cases.

Investigators said Sullenberger acknowledged it contained her own urine which she believed was drug-free, which she planned to use to pass the test. Sullenberger faces a preliminary hearing Dec. 12.